CPMA Canine parvovirus monoclonal antibody (CPMA) is a synthetic antibody treatment for parvovirus in dogs that is conditionally approved by the USDA. It's a one-time intravenous injection that neutralizes the virus by mimicking a dog's antibodies and preventing it from entering cells. CPMA is most effective when administered early after diagnosis. Here is an overview of CPMA treatment:
Efficacy
When administered as the sole therapy at the first positive test, CPMA has shown 100% efficacy in preventing mortality.
Symptoms
CPMA can reduce the severity of symptoms like vomiting, diarrhea, fever, and lack of appetite.
Hospitalization
CPMA can reduce hospitalization time by helping practitioners treat puppies faster.
Cost
A vial of CPMA costs around $200 and is effective for dogs up to 11 pounds. Treating larger dogs can cost over $1,000. How CPMA Works: CPMA is a synthetic antibody that binds to and neutralizes the parvovirus, preventing it from infecting and damaging cells in the dog's body. This helps to reduce the severity of the infection and improve the chances of survival. Benefits of CPMA:
Improves survival rates:
Studies have shown that CPMA significantly increases the survival rate of dogs with parvovirus.
Reduces severity of symptoms:
CPMA can help to reduce the severity of symptoms, such as vomiting, diarrhea, and lethargy.
Shortens recovery time:
CPMA can help to shorten the recovery time for dogs with parvovirus.
Targeted treatment:
CPMA is a specific treatment for parvovirus, which means it targets the virus directly and does not have side effects that may affect other parts of the dog's body. Administration: CPMA is administered as an intravenous injection. It is typically given as a single dose but may be repeated in some cases. Availability and Cost: CPMA is available through licensed veterinarians. The cost of CPMA may vary depending on the veterinarian and the dog's weight. Other Treatment Options: In addition to CPMA, other treatments for parvovirus include: Intravenous fluids and electrolytes, Anti-nausea medications, Antibiotics (if there is a secondary bacterial infection), and Pain relievers. Conclusion: CPMA is an effective and innovative treatment for canine parvovirus. It can significantly improve the chances of survival and reduce the severity of the infection. If your dog is diagnosed with parvovirus, it is important to consult with a veterinarian to discuss the best treatment options available. What is the survival rate for Cpma parvo treatment? 93% “Without supportive care, parvo has a 91% mortality rate. However, there's a treatment beyond just supportive care – Elanco's CPMA which can help defend puppies and defeat parvo. In real-world usage, 93% of parvo-infected puppies treated with CPMA survived. April 2025 AI Overview You cannot directly buy CPMA (Canine Parvovirus Monoclonal Antibody) treatment yourself; it must be administered by a veterinarian. You need to contact your local vet or an emergency animal hospitalto inquire if they stock CPMA and can administer it to your dog. Other options include contacting shelters or humane societies that have used the treatment, though it is often costly and may require support from donations. Where to seek treatment
CPMA is a prescription-based treatment that requires professional administration by a licensed veterinarian.
Not available for home use:
It is not sold directly to pet owners for home use.
High cost:
CPMA can be expensive, and the cost can increase for larger dogs, but it is a highly effective treatment that has improved survival rates significantly, according to Elanco.
